JPRN-UMIN000031703Completed未知
Oral Beclometasone dipropionate for for gut GVHD - BDP for gut GVHD
Department of Pediatrics, University of Ryukyus, hospital0 sites1 target enrollmentStarted: March 15, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 1
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 11years-old to 11years-old (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •no active cytomegalovirus (CMV) infection and no CMV antigenemia for confirmed endoscopically gut GVHD
Investigators
Similar Trials
Completed
Not Applicable
Oral beclomethasone dipropionate treatment for gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantatioPatients with symptoms of acute gastrointestinal GVHD after allo-HSCTJPRN-UMIN000027026Tokyo Women's Medical University, Department of Hematology5
Active, not recruiting
Not Applicable
Efficacy and safety of beclometasone dipropionate (BDP) gastro-resistant prolonged release tablets (CHF1514) compared to oral steroid (prednisone) in an 8-week treatment period in patients with active moderate ulcerative colitis. A multicentre, randomised, controlled, double blind, parallel group study. Beta study - BETAMild moderate active ulcerative colitisMedDRA version: 9.1Level: LLTClassification code 10009900Term: Colitis ulcerativeEUCTR2006-004230-32-ITCHIESI300
Completed
Not Applicable
The efficacy and safety of oral Beclomethasone dipropionate (BDP) in patients with gastrointestinal acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation FBMTG BDP17Hematologic disorders Gastrointestinal acute GVHDJPRN-UMIN000025116FBMTG35
Completed
Not Applicable
The efficacy and safety of oral Beclomethasone dipropionate (BDP) in patients with gastrointestinal acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantatioHematologic disorders Gastrointestinal acute GVHDJPRN-UMIN000010750Fukuoka Blood and Marrow Transplantation Group35
Completed
Phase 1
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonChronic Myeloproliferative DisordersGestational Trophoblastic TumorGraft Versus Host DiseaseKidney CancerMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesTesticular Germ Cell TumorBreast CancerOvarian CancerLymphomaLeukemiaNeuroblastomaNCT00010283Fred Hutchinson Cancer Center